Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 116

1.

Induction of HIV-1-specific cellular and humoral immune responses following immunization with HIV-DNA adjuvanted with activated apoptotic lymphocytes.

Brave A, Johansson U, Hallengärd D, Heidari S, Gullberg H, Wahren B, Hinkula J, Spetz AL.

Vaccine. 2010 Feb 25;28(9):2080-7. doi: 10.1016/j.vaccine.2009.12.040. Epub 2009 Dec 29.

PMID:
20044053
[PubMed - indexed for MEDLINE]
2.

Maternal immune status influences HIV-specific immune responses in pups after DNA prime protein boost using mucosal adjuvant.

Bråve A, Johansen K, Palma P, Benthin R, Hinkula J.

Vaccine. 2008 Nov 5;26(47):5957-66. doi: 10.1016/j.vaccine.2008.08.060. Epub 2008 Sep 16.

PMID:
18801400
[PubMed - indexed for MEDLINE]
3.

HIV-1 DNA vaccine efficacy is enhanced by coadministration with plasmid encoding IFN-alpha.

Jiang W, Ren L, Jin N.

J Virol Methods. 2007 Dec;146(1-2):266-73. Epub 2007 Sep 14.

PMID:
17868910
[PubMed - indexed for MEDLINE]
4.

Neutralizing activity and cellular immune responses induced in mice after immunization with apoptotic HIV-1/murine leukemia virus infected cells.

Hinkula J, Walther-Jallow L, Laurén A, Mäkitalo B, Oberg M, Wahren B, Fenyö EM, Spetz AL.

Vaccine. 2009 Oct 30;27(46):6424-31. doi: 10.1016/j.vaccine.2009.06.016. Epub 2009 Jun 21.

PMID:
19549607
[PubMed - indexed for MEDLINE]
5.

Comparative ability of various plasmid-based cytokines and chemokines to adjuvant the activity of HIV plasmid DNA vaccines.

Xu R, Megati S, Roopchand V, Luckay A, Masood A, Garcia-Hand D, Rosati M, Weiner DB, Felber BK, Pavlakis GN, Sidhu MK, Eldridge JH, Egan MA.

Vaccine. 2008 Sep 2;26(37):4819-29. doi: 10.1016/j.vaccine.2008.06.103. Epub 2008 Jul 25.

PMID:
18657584
[PubMed - indexed for MEDLINE]
6.

Modifying the HIV-1 env gp160 gene to improve pDNA vaccine-elicited cell-mediated immune responses.

Megati S, Garcia-Hand D, Cappello S, Roopchand V, Masood A, Xu R, Luckay A, Chong SY, Rosati M, Sackitey S, Weiner DB, Felber BK, Pavlakis GN, Israel ZR, Smith LR, Eldridge JH, Sidhu MK, Egan MA.

Vaccine. 2008 Sep 19;26(40):5083-94. doi: 10.1016/j.vaccine.2008.03.092. Epub 2008 Apr 24.

PMID:
18485543
[PubMed - indexed for MEDLINE]
7.

Evaluation of immunogenicity and efficacy of combined DNA and adjuvanted protein vaccination in a human immunodeficiency virus type 1/murine leukemia virus pseudotype challenge model.

Rollman E, Mathy N, Bråve A, Boberg A, Kjerrström A, van Wely C, Engström G, Johansson S, Aperia K, Eriksson LE, Benthin R, Ertl P, Heeney J, Hinkula J, Voss G, Wahren B.

Vaccine. 2007 Mar 1;25(11):2145-54. Epub 2006 Nov 13.

PMID:
17254672
[PubMed - indexed for MEDLINE]
8.

Enhancement of immune responses to an HIV env DNA vaccine by a C-terminal segment of listeriolysin O.

Bu Z, Ye L, Skeen MJ, Ziegler HK, Compans RW, Yang C.

AIDS Res Hum Retroviruses. 2003 May;19(5):409-20.

PMID:
12803999
[PubMed - indexed for MEDLINE]
9.

Novel codon-optimized GM-CSF gene as an adjuvant to enhance the immunity of a DNA vaccine against HIV-1 Gag.

Qiu JT, Chang TC, Lin CT, Chen YM, Li FQ, Soong YK, Lai CH.

Vaccine. 2007 Jan 4;25(2):253-63. Epub 2006 Aug 4.

PMID:
16971027
[PubMed - indexed for MEDLINE]
10.

Novel engineered HIV-1 East African Clade-A gp160 plasmid construct induces strong humoral and cell-mediated immune responses in vivo.

Muthumani K, Zhang D, Dayes NS, Hwang DS, Calarota SA, Choo AY, Boyer JD, Weiner DB.

Virology. 2003 Sep 15;314(1):134-46.

PMID:
14517067
[PubMed - indexed for MEDLINE]
Free Article
11.

Combining DNA technologies and different modes of immunization for induction of humoral and cellular anti-HIV-1 immune responses.

Bråve A, Hallengärd D, Malm M, Blazevic V, Rollman E, Stanescu I, Krohn K.

Vaccine. 2009 Jan 7;27(2):184-6. doi: 10.1016/j.vaccine.2008.10.041. Epub 2008 Nov 4.

PMID:
18992294
[PubMed - indexed for MEDLINE]
12.

Combined effects of IL-12 and electroporation enhances the potency of DNA vaccination in macaques.

Hirao LA, Wu L, Khan AS, Hokey DA, Yan J, Dai A, Betts MR, Draghia-Akli R, Weiner DB.

Vaccine. 2008 Jun 13;26(25):3112-20. doi: 10.1016/j.vaccine.2008.02.036. Epub 2008 Mar 11.

PMID:
18430495
[PubMed - indexed for MEDLINE]
13.

Topical application of HIV DNA vaccine with cytokine-expression plasmids induces strong antigen-specific immune responses.

Liu LJ, Watabe S, Yang J, Hamajima K, Ishii N, Hagiwara E, Onari K, Xin KQ, Okuda K.

Vaccine. 2001 Oct 12;20(1-2):42-8.

PMID:
11567744
[PubMed - indexed for MEDLINE]
14.

Preclinical evaluation of cellular immune responses elicited by a polyvalent DNA prime/protein boost HIV-1 vaccine.

Cristillo AD, Wang S, Caskey MS, Unangst T, Hocker L, He L, Hudacik L, Whitney S, Keen T, Chou TH, Shen S, Joshi S, Kalyanaraman VS, Nair B, Markham P, Lu S, Pal R.

Virology. 2006 Mar 1;346(1):151-68. Epub 2005 Dec 2.

PMID:
16325880
[PubMed - indexed for MEDLINE]
Free Article
15.

ELISPOT analysis of a new CTL based DNA vaccine for HIV-1 using GM-CSF in DNA prime/peptide boost strategy: GM-CSF induced long-lived memory responses.

Mahdavi M, Ebtekar M, Khorram Khorshid HR, Azadmanesh K, Hartoonian C, Hassan ZM.

Immunol Lett. 2011 Oct 30;140(1-2):14-20. doi: 10.1016/j.imlet.2011.05.005. Epub 2011 May 23.

PMID:
21679728
[PubMed - indexed for MEDLINE]
16.

Intranasal immunization of young mice with a multigene HIV-1 vaccine in combination with the N3 adjuvant induces mucosal and systemic immune responses.

Bråve A, Hallengärd D, Schröder U, Blomberg P, Wahren B, Hinkula J.

Vaccine. 2008 Sep 19;26(40):5075-8. doi: 10.1016/j.vaccine.2008.03.066. Epub 2008 Apr 15.

PMID:
18450334
[PubMed - indexed for MEDLINE]
17.

Induction of gp120-specific protective immune responses by genetic vaccination with linear polyethylenimine-plasmid complex.

Garzón MR, Berraondo P, Crettaz J, Ochoa L, Vera M, Lasarte JJ, Vales A, Van Rooijen N, Ruiz J, Prieto J, Zulueta J, González-Aseguinolaza G.

Vaccine. 2005 Feb 3;23(11):1384-92.

PMID:
15661387
[PubMed - indexed for MEDLINE]
18.

Efficient augmentation of a long-lasting immune responses in HIV-1 gag DNA vaccination by IL-15 plasmid boosting.

Li W, Li S, Hu Y, Tang B, Cui L, He W.

Vaccine. 2008 Jun 19;26(26):3282-90. doi: 10.1016/j.vaccine.2008.03.081. Epub 2008 Apr 18.

PMID:
18472194
[PubMed - indexed for MEDLINE]
19.

An HIV-based lentiviral vector as HIV vaccine candidate: Immunogenic characterization.

Lemiale F, Asefa B, Ye D, Chen C, Korokhov N, Humeau L.

Vaccine. 2010 Feb 23;28(8):1952-61. doi: 10.1016/j.vaccine.2009.10.089.

PMID:
20188251
[PubMed - indexed for MEDLINE]
20.

Potent CD4+ T cell responses elicited by a bicistronic HIV-1 DNA vaccine expressing gp120 and GM-CSF.

Barouch DH, Santra S, Tenner-Racz K, Racz P, Kuroda MJ, Schmitz JE, Jackson SS, Lifton MA, Freed DC, Perry HC, Davies ME, Shiver JW, Letvin NL.

J Immunol. 2002 Jan 15;168(2):562-8.

PMID:
11777947
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk